Joint Programming Initiative on Antimicrobial Resistance
Dela
Antimicrobial resistance is a global problem that presents a major public health challenge. The aim of JPIAMR is to integrate relevant research activities across national borders. The need for this initiative is obvious – bacteria and other infecting agents know no borders and therefore trans-national cooperation is crucial. A shared strategic research and innovation agenda guides the research fun
16/01/2023
The call is open!
A joint research call on and ! Est. budget: 18.8 Million Euro.
18 countries participate, providing funding for researchers in national contexts.
See call page: https://jpiamr.eu/calls/diagnostics-surveillance-call-2023/.
05/12/2022
It's open!
We invite researchers, stakeholders, scientists, policymakers, clinicians, patient groups, AMR-related organisations, and others to provide feedback on the Research and Innovations Objectives!
👉 https://www.jpiamr.eu/open-consultation-oh-amr-research-and-innovation-objectives/
We are happy to share the results from the 14th JPIAMR call!
It aims to improve the treatment of bacterial and fungal infections, to prevent the spread of resistance in humans, animals, or plants by improving drugs and plant protection agents. . Please view the projects recommended for funding here: www.jpiamr.eu/calls/therapeutics-call-2022/
05/07/2022
"Preventing antimicrobial resistance together"
Excellent theme for this year's World Antibiotic Awareness Week! 👉http://createsend.com/t/d-AFC3192DB8A403632540EF23F30FEDED
14/06/2022
Soon!
JPIAMR, in partnership with U.Ks Medical Research Council and BactiVac Network, hosts a live webinar to identify opportunities and priorities for vaccine research. Vaccinations are effective in promoting the prudent use of antibiotics and preventing the spread of .
Register here: https://www.jpiamr.eu/events/vaccination-as-a-strategy-to-combat-antimicrobial-resistance/
10/06/2022
Have your say in directing the future of !
We are happy to host this workshop with KTN! We will explore the main barriers to the industry in developing novel antibacterial drugs for humans and how JPIAMR and other stakeholders (industry, academia, funders, and regulatory agencies, among others) can work together to improve the translation of these developments.
Join here 👉 https://www.jpiamr.eu/events/developing-novel-antimicrobial-therapeutics/
Klicka här för att få din sponsrade notering.
Kontakta affären
Telefon
Webbplats
Adress
Hantverkargatan 11B
Stockholm
11221
